Hill NR Fatoba ST Oke JL et al.

Global prevalence of chronic kidney disease - a systematic review and meta-analysis.

PLoS One. 11e0158765https://doi.org/10.1371/journal.pone.0158765GBD Chronic Kidney Disease Collaboration

Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 395: 709-733https://doi.org/10.1016/S0140-6736(20)30045-3Couser WG Remuzzi G Mendis S Tonelli M.

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.

Kidney Int. 80: 1258-1270https://doi.org/10.1038/ki.2011.368Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group

KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.

Kidney Int. 3: 1-150

Prediction of creatinine clearance from serum creatinine.

Nephron. 16: 31-41https://doi.org/10.1159/000180580Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D.

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Ann Intern Med. 130: 461-470https://doi.org/10.7326/0003-4819-130-6-199903160-00002Froissart M Rossert J Jacquot C Paillard M Houillier P.

Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.

J Am Soc Nephrol. 16: 763-773https://doi.org/10.1681/ASN.2004070549Cirillo M Anastasio P De Santo NG.

Relationship of gender, age, and body mass index to errors in predicted kidney function.

Nephrol Dial Transplant. 20: 1791-1798https://doi.org/10.1093/ndt/gfh962Florkowski CM Chew-Harris JS.

Methods of estimating GFR - different equations including CKD-EPI.

Clin Biochem Rev. 32: 75-79Levey A Stevens L Schmid C et al.

A new equation to estimate glomerular filtration rate.

Ann Intern Med. 150: 604-612Inker LA Levey AS Tighiouart H et al.

Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis.

Nephrol Dial Transplant. 33: 417-425https://doi.org/10.1093/ndt/gfx042Wetzels JF Willems HL den Heijer M.

Age- and gender-specific reference values of estimated glomerular filtration rate in a Caucasian population: results of the Nijmegen Biomedical Study.

Kidney Int. 73: 657-658https://doi.org/10.1038/sj.ki.5002755Mattix H Hsu C Shaykevich S Curhan G.

Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race.

J Am Soc Nephrol. 14: 1034-1039Johnson DW Jones GR Mathew TH et al.

Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement.

Med J Aust. 197: 224-225https://doi.org/10.5694/mja11.11468Mills KT Xu Y Zhang W et al.

A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.

Kidney Int. 88: 950-957https://doi.org/10.1038/ki.2015.230Xie Y Bowe B Mokdad AH et al.

Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.

Kidney Int. 94: 567-581https://doi.org/10.1016/j.kint.2018.04.011

Molecular mechanisms of renal aging.

Kidney Int. 92: 569-579https://doi.org/10.1016/j.kint.2017.02.036

Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease.

Nephron. 134: 25-29https://doi.org/10.1159/000445450Levin A Tonelli M Bonventre J et al.

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.

Lancet. 390: 1888-1917https://doi.org/10.1016/S0140-6736(17)30788-2McClellan WM Flanders WD.

Risk factors for progressive chronic kidney disease.

J Am Soc Nephrol. 14: S65-S70https://doi.org/10.1097/01.asn.0000070147.10399.9eAlicic RZ Rooney MT Tuttle KR.

Diabetic kidney disease: challenges, progress, and possibilities.

Clin J Am Soc Nephrol. 12: 2032-2045https://doi.org/10.2215/CJN.11491116

White SL. Chronic Kidney Disease, Diabetes & Cardiovascular Disease: Evidence Report 2021. Kidney Health Australia, Melbourne, Australia, August 2020.

Hovind P Tarnow L Rossing P et al.

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.

BMJ. 328: 1105https://doi.org/10.1136/bmj.38070.450891.FEOrchard TJ Dorman JS Maser RE et al.

Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II.

Diabetes. 39: 1116-1124https://doi.org/10.2337/diab.39.9.1116Raile K Galler A Hofer S et al.

Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.

Diabetes Care. 30: 2523-2528https://doi.org/10.2337/dc07-0282Shen Y Cai R Sun J et al.

Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis.

Endocrine. 55: 66-76

US Renal Data System. 2020 USRDS annual data report: epidemiology of kidney disease in the United States. 2020. Accessed August 3, 2022. https://adr.usrds.org/2020

Weldegiorgis M Woodward M.

The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis.

BMC Nephrol. 21: 506Garcia-Carro C Vergara A Bermejo S Azancot MA Sellares J Soler MJ.

A nephrologist perspective on obesity: from kidney injury to clinical management.

Front Med (Lausanne). 8655871https://doi.org/10.3389/fmed.2021.655871Kovesdy C Furth S Zoccali C

on behalf of the World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic.

Can J Kidney Health Dis. 4

Kidney Health Australia. Obesity and chronic kidney disease: the hidden impact. Accessed March 1, 2022. https://kidney.org.au/uploads/resources/kidney-health-australia-report-obesity-and-chronic-kidney-disease-the-hidden-impact_06.03.17.pdf

Wang Y Chen X Song Y Caballero B Cheskin L.

Association between obesity and kidney disease: a systematic review and meta-analysis.

Kidney Int. 73: 19-33Memarian E Nilsson PM Zia I Christensson A Engstrom G

The risk of chronic kidney disease in relation to anthropometric measures of obesity: a Swedish cohort study.

BMC Nephrol. 22: 330https://doi.org/10.1186/s12882-021-02531-7He Y Li F Wang F Ma X Zhao X Zeng Q.

The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults.

Medicine. 95: e3769

Chronic kidney disease is a risk factor for stroke.

J Stroke Cerebrovasc Dis. 30105730Lu R Kiernan MC Murray A Rosner MH Ronco C.

Kidney-brain crosstalk in the acute and chronic setting.

Nat Rev Nephrol. 11: 707-719https://doi.org/10.1038/nrneph.2015.131Wu CL Tsai CC Kor CT et al.

Stroke and risks of development and progression of kidney diseases and end-stage renal disease: a nationwide population-based cohort study.

PLoS One. 11e0158533https://doi.org/10.1371/journal.pone.0158533Fang MC Singer DE Chang Y et al.

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Circulation. 112: 1687-1691https://doi.org/10.1161/circulationaha.105.553438Reeves MJ Bushnell CD Howard G et al.

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.

Lancet Neurol. 7: 915-926https://doi.org/10.1016/S1474-4422(08)70193-5

Smoking is a risk factor in the progression to kidney failure.

Kidney Int. 80: 516-523

Association of smoking with incident CKD risk in the general population: a community-based cohort study.

PLoS One. 15e0238111https://doi.org/10.1371/journal.pone.0238111Briganti E Branley P Chadban S et al.

Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study.

Am J Kidney Dis. 40: 704-712

Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies.

Nephrol Dial Transplant. 32: 475-487https://doi.org/10.1093/ndt/gfw452

Office of Disease Prevention and Health Promotion. Disparities. Accessed March 1, 2022. https://www.healthypeople.gov/2020/about/foundation-health-measures/Disparities

World Health Organisation. Social determinants of health: key concepts. Accessed January 3, 2022. https://www.who.int/news-room/questions-and-answers/item/social-determinants-of-health-key-concepts

Clark-Cutaia MN Rivera E Iroegbu C Squires A.

Disparities in chronic kidney disease-the state of the evidence.

Curr Opin Nephrol Hypertens. 30: 208-214https://doi.org/10.1097/MNH.0000000000000688

Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 395: 709-733https://doi.org/10.1016/s0140-6736(20)30045-3Thurlow JS Joshi M Yan G et al.

Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy.

Am J Nephrol. 52: 98-107https://doi.org/10.1159/000514550Ozieh MN Garacci E Walker RJ Palatnik A Egede LE.

The cumulative impact of social determinants of health factors on mortality in adults with diabetes and chronic kidney disease.

BMC Nephrol. 22: 76https://doi.org/10.1186/s12882-021-02277-2

ANZDATA Registry. 43rd report, Kidney Transplantation Australia and New Zealand Dialysis and Transplant Registry. 2022. Accessed August 3, 2022. http://www.anzdata.org.au

Australian Government Productivity Commission. Strong economic participation and development of Aboriginal and Torres Strait Islander people and communities. Accessed March 1, 2022. https://www.pc.gov.au/closing-the-gap-data/dashboard/socioeconomic/outcome-area8

Vart P van Zon SKR Gansevoort RT Bultmann U Reijneveld SA.SES

chronic kidney disease, and race in the U.S.: a systematic review and meta-analysis.

Am J Prev Med. 53: 730-739https://doi.org/10.1016/j.amepre.2017.06.036Ritte RE Lawton P Hughes JT et al.

Chronic kidney disease and socio-economic status: a cross sectional study.

Ethn Health. 25: 93-109https://doi.org/10.1080/13557858.2017.1395814Fedewa SA McClellan WM Judd S Gutiérrez OM Crews DC.

The association between race and income on risk of mortality in patients with moderate chronic kidney disease.

BMC Nephrol. 15: 136https://doi.org/10.1186/1471-2369-15-136Cobo G Hecking M Port FK et al.

Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis.

Clin Sci (Lond). 130: 1147-1163https://doi.org/10.1042/CS20160047Bolignano D Mattace-Raso F Sijbrands EJ Zoccali C.

The aging kidney revisited: a systematic review.

Ageing Res Rev. 14: 65-80https://doi.org/10.1016/j.arr.2014.02.003Evans M Fryzek JP Elinder CG et al.

The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.

Am J Kidney Dis. 46: 863-870https://doi.org/10.1053/j.ajkd.2005.07.040Halbesma N Brantsma AH Bakker SJ et al.

Gender differences in predictors of the decline of renal function in the general population.

Kidney Int. 74: 505-512https://doi.org/10.1038/ki.2008.200Neugarten J Acharya A Silbiger SR.

Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

J Am Soc Nephrol. 11: 319-329https://doi.org/10.1681/ASN.V112319Jafar TH Schmid CH Stark PC et al.

The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

Nephrol Dial Transplant. 18: 2047-2053https://doi.org/10.1093/ndt/gfg317Turin TC James M Ravani P et al.

Proteinuria and rate of change in kidney function in a community-based population.

J Am Soc Nephrol. 24: 1661-1667https://doi.org/10.1681/ASN.2012111118Morton RL Turner RM Howard K Snelling P Webster AC.

Patients who plan for conservative care rather than dialysis: a national observational study in Australia.

Am J Kidney Dis. 59: 419-427https://doi.org/10.1053/j.ajkd.2011.08.024Antlanger M Noordzij M van de Luijtgaarden M et al.

Sex differences in kidney replacement therapy initiation and maintenance.

Clin J Am Soc Nephrol. 14: 1616-1625https://doi.org/10.2215/CJN.04400419De La Mata NL Rosales B MacLeod G et al.

Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage study.

BMJ. 375e068247https://doi.org/10.1136/BMJ-2021-068247Fanelli C Delle H Cavaglieri RC Dominguez WV Noronha IL.

Gender differences in the progression of experimental chronic kidney disease induced by chronic nitric oxide inhibition.

Biomed Res Int. ()2159739https://doi.org/10.1155/2017/2159739Valdivielso JM Jacobs-Cacha C Soler MJ.

Sex hormones and their influence on chronic kidney disease.

Curr Opin Nephrol Hypertens. 28: 1-9https://doi.org/10.1097/MNH.0000000000000463Kattah AG Smith CY Gazzuola Rocca L Grossardt BR Garovic VD Rocca WA

CKD in patients with bilateral oophorectomy.

Clin J Am Soc Nephrol. 13: 1649-1658https://doi.org/10.2215/CJN.03990318Ji H Pesce C Zheng W et al.

Sex differences in renal injury and nitric oxide production in renal wrap hypertension.

Am J Physiol Heart Circ Physiol. 288: H43-H47https://doi.org/10.1152/ajpheart.00630.2004Forte P Kneale BJ Milne E et al.

Evidence for a difference in nitric oxide biosynthesis between healthy women and men.

Hypertension. 32: 730-734https://doi.org/10.1161/01.hyp.32.4.730Pscheidt C Nagel G Zitt E Kramar R Concin H Lhotta K.

Sex- and time-dependent patterns in risk factors of end-stage renal disease: a large Austrian cohort with up to 20 years of follow-up.

PLoS One. 10e0135052https://doi.org/10.1371/journal.pone.0135052Jankowski J Floege J Fliser D Bohm M Marx N.

Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options.

Circulation. 143: 1157-1172https://doi.org/10.1161/circulationaha.120.050686O'Lone E Kelly PJ Masson P et al.

Incidence of ischaemic heart disease in men and women with end-stage kidney disease: a cohort study.

Heart Lung Circ. 29: 1517-1526https://doi.org/10.1016/j.hlc.2020.03.002Masson P Kelly PJ Craig JC Lindley RI Webster AC.

Risk of stroke in patients with ESRD.

Clin J Am Soc Nephrol. 10: 1585-1592https://doi.org/10.2215/CJN.12001214

US Rednal Data System. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. 2020. Accessed August 3, 2022. https://adr.usrds.org/2020

Do sex and gender matter in kidney and cardiovascular disease?.

Am J Kidney Dis. 78: 177-179Nitsch D Grams M Sang Y et al.

Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.

BMJ. 346: f324https://doi.org/10.1136/bmj.f324Appelman Y van Rijn BB Ten Haaf ME Boersma E Peters SA

Sex differences in cardiovascular risk factors and disease prevention.

Atherosclerosis. 241: 211-218https://doi.org/10.1016/j.atherosclerosis.2015.01.027Ray JG Vermeulen MJ Schull MJ Redelmeier DA.

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study.

Lancet. 366: 1797-1803https://doi.org/10.1016/S0140-6736(05)67726-4Bramham K Seed PT Lightstone L et al.

Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease.

Kidney Int. 89: 874-885https://doi.org/10.1016/j.kint.2015.10.012Mol BWJ Roberts CT Thangaratinam S Magee LA de Groot CJM Hofmeyr GJ.

Pre-eclampsia.

Lancet. 387: 999-1011https://doi.org/10.1016/S0140-6736(15)00070-7

Sex hormones in women with kidney disease.

Nephrol Dial Transplant. 31: 1787-1795https://doi.org/10.1093/ndt/gfw084

The effect of testosterone on cardiovascular disease and cardiovascular risk factors in men: a review of clinical and preclinical data.

CJC Open. 3: 1238-1248https://doi.org/10.1016/j.cjco.2021.05.007Iorga A Cunningham CM Moazeni S Ruffenach G Umar S Eghbali M.

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.

Biol Sex Differ. 8: 33https://doi.org/10.1186/s13293-017-0152-8Farahmand M Ramezani Tehrani F Khalili D Cheraghi L Azizi F

Endogenous estrogen exposure and chronic kidneydisease; a 15-year prospective cohort study.

BMC Endocr Disord. 21: 155https://doi.org/10.1186/s12902-021-00817-3Kim HS Ng DK Matheson MB et al.

Delayed menarche in girls with chronic kidney disease and the association with short stature.

Pediatr Nephrol. 35: 1471-1475https://doi.org/10.1007/s00467-020-04559-7Gold EB Crawford SL Avis NE et al.

Factors related to age at natural menopause: longitudinal analyses from SWAN.

Am J Epidemiol. 178: 70-83https://doi.org/10.1093/aje/kws421Kramer HM Curhan GC Singh A

Hemodialysis, Estrogen Levels in Postmenopausal Patients Study Group. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study.

Am J Kidney Dis. 41: 643-650https://doi.org/10.1053/ajkd.2003.50126Vellanki K Hou S. Menopause in CKD. Am J Kidney Dis. 71: 710-719https://doi.org/10.1053/j.ajkd.2017.12.019

The timing of the age at which natural menopause occurs.

Obstet Gynecol Clin North Am. 38: 425-440https://doi.org/10.1016/j.ogc.2011.05.002

Emerging research on the implications of hormone replacement therapy on coronary heart disease.

Curr Atheroscler Rep. 20: 57https://doi.org/10.1007/s11883-018-0758-2Tonelli M Sacks F Pfeffer M et al.

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.

Circulation. 112: 2627-2633https://doi.org/10.1161/circulationaha.105.553198Ix JH Chonchol M Laughlin GA Shlipak MG Whooley MA.

Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study.

Am J Kidney Dis. 58: 737-745https://doi.org/10.1053/j.ajkd.2011.06.011Gutierrez OM Mannstadt M Isakova T et al.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

N Engl J Med. 359: 584-592https://doi.org/10.1056/nejmoa0706130Perunicic-Pekovic G Pljesa S Rasic-Milutinovic Z Stankovic S Ilic M Maletic R.

Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.

Can J Physiol Pharmacol. 86: 205-209https://doi.org/10.1139/Y08-018

The effect of gender on survival for hemodialysis patients: why don't women live longer than men?.

Semin Dial. 32: 438-443https://doi.org/10.1111/sdi.12817

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.

Kidney Int. 70: 2021-2030https://doi.org/10.1038/sj.ki.5001934Khan E Brieger D Amerena J et al.

Differences in management and outcomes for men and women with ST-elevation myocardial infarction.

Med J Aust. 209: 118-123https://doi.org/10.5694/mja17.01109Huxley R Barzi F Woodward M.

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

BMJ. 332: 73-78https://doi.org/10.1136/bmj.38678.389583.7CYusuf S Hawken S Ounpuu S et al.

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Lancet. 364: 937-952https://doi.org/10.1016/S0140-6736(04)17018-9Flink L Mochari-Greenberger H Mosca L.

Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease.

Am Heart J. 165: 972-978

Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis.

Endocr Rev. 15: 301-309https://doi.org/10.1210/edrv-15-3-301Almaden Y Felsenfeld AJ Rodriguez M et al.

Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender.

Kidney Int. 64: 2311-2317https://doi.org/10.1046/j.1523-1755.2003.00331.xNaveh-Many T Volovelsky O.

Parathyroid cell proliferation in secondary hyperparathyroidism of chronic kidney disease.

Int J Mol Sci. 21: 4332https://doi.org/10.3390/ijms21124332Satirapoj B Limwannata P Chaiprasert A Supasyndh O Choovichian P.

Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population.

BMC Nephrol. 14: 206https://doi.org/10.1186/1471-2369-14-206Jean G Souberbielle J Chazot C.

Vitamin D in chronic kidney disease and dialysis patients.

Nutrients. 9: 328Filipov J Zlatkov B Dimitrov E Svinarov D.

Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients.

Biotechnol Biotechnol Equip. 29: 331-335Mohiuddin S Marie M Ashraf M Hussein M Almalki N.

Is there an association between vitamin D level and inflammatory markers in hemodialysis patients? A cross-sectional study.

Saudi J Kidney Dis Transpl. 27: 460-466Ravani P Malberti F Tripepi G et al.

Vitamin D levels and patient outcome in chronic kidney disease.

Kidney Int. 75: 88-95https://doi.org/10.1038/ki.2008.501Rohrmann S Braun J Bopp M Faeh D.

Inverse association between circulating vitamin D and mortality–dependent on sex and cause of death?.

Nutr Metab Cardiovasc Dis. 23: 960-966Serdar MA Batu Can B Kilercik M et al.

Analysis of change